Please select an option below to help us tailor your newsletter to best suit your content interests!
Dr. Jason Porter details groundbreaking research for KRAS-mutant NSCLC during a Targeted Oncology Community Case Forum. 🎉 Explore the CodeBreaK 100 and CodeBreaK 200 studies, showing promising results and insights into new treatment strategies. Read more about the accelerated approval of new treatment options, and their impact on patients’ lives. Let’s revolutionize #LungCancer care together!… Read more »
Our very own Dr. Jason Porter was a recent guest on the Research Evangelist Podcast. This podcast hosts weekly discussions with leaders in the lung cancer research community. Host, David Bjork, is a lung cancer survivor himself and patient advocate. He and Dr. Porter discuss molecularly-altered lung cancers, as well as those lung cancers with… Read more »
Our West Family is excited to launch a lung screening program at several of our campuses across the MidSouth! Patients and referring providers can schedule an appointment to receive a low-dose CT scan to detect lung cancer early. We accept all major insurance carriers and patients must meet the following criteria: – Between the ages of… Read more »
Click here to view this full article on OncLive.com. The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »